Practical guidelines for diagnostic use of in vitro chemosensitivity tests

Anticancer Research

Volumn 27, Issue 3 A, 2007, Pages 1365-1367

  Schinköthe, Timo ^a   Haeger, Svenja ^a   Gabri, Mariano R ^a  

^a TumorTec GmbH   (Germany)

Author keywords

Chemoresistance; Chemosensitivity; Cytostatic drugs; In vitro diagnostics; Tumour

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOSTATIC AGENT;

CHEMOSENSITIVITY; CLINICAL PRACTICE; CONFERENCE PAPER; CYTOSTASIS; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG SENSITIVITY; HUMAN; IN VITRO STUDY; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT PLANNING;

ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; GUIDELINES; HUMANS; NEOPLASMS;

EID: 34249311306     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. Black MM and Speer FD: Further observations on the effects of cancer chemotherapeutic agents on the in vitro dehydrogenase activity of cancer tissue. J Natl Cancer Inst 14: 1147-1158, 1954.
2. Kurbacher CM, Cree IA, Bruckner HW, Brenne U, Kurbacher JA, Muller K, Ackermann T, Gilster TJ, Wilhelm LM, Engel H, Mallmann PK and Andreotti PE: Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer. Anticancer Drugs 9: 51-57, 1998.
3. Loizzi V, Chan JK, Osann K, Cappuccini F, DiSaia PJ, and Berman ML: Survival outcomes in patients with recurrent ovarian cancer who were treated with chemoresistance assay-guided chemotherapy. Am J Obstet Gynecol 189: 1301-1307, 2003.
4. Maenpaa JU, Heinonen E, Hinkka SM, Karnani P, Klemi PJ, Korpijaakko TA, Kuoppala TA, Laine AM, Lahde MA, Nuoranne EK, Puolakka JO, Ranta TT, Rhen KE, Salmi MA, Suonio E, Taina EJ, Tuominen JE, Tuomisto L and Väyrynen MA: The subrenal capsule assay in selecting chemotherapy for ovarian cancer: a prospective randomized trial. Gynecol Oncol 57: 294-298, 1995.
5. Schrag D, Garewal HS, Burstein HJ, Samson DJ, Von Hoff DD and Somerfield MR: American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays. J Clin Oncol 22: 3631-3638, 2004.
6. Staib P, Staltmeier E, Neurohr K, Cornely O, Reiser M and Schinköthe T: Prediction of individual response to chemotherapy in patients with acute myeloid leukaemia using the chemosensitivity index Ci. Br J Haematol 128: 783-791, 2005.
7. Von Hoff DD, Clark GM, Stogdill BJ, Sarosdy MF, O'Brien MT, Casper JT, Mattox DE, Page CP, Cruz AB and Sandbach JF: Prospective clinical trial of a human tumor cloning system. Cancer Res 43: 1926-1931, 1983.
8. Von Hoff DD, Sandbach JF, Clark GM, Turner JN, Forseth BF, Piccart MJ, Colombo N and Muggia FM: Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician. J Natl Cancer Inst 82: 110-116, 1990.
9. Xu JM, Song ST, Tang ZM, Jiang ZF, Liu XQ, Zhou L, Zhang J and Liu XW: Predictive chemotherapy of advanced breast cancer directed by MTT assay in vitro. Breast Cancer Res Treat 53: 77-85, 1999.